TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Advanced Parenteral Drug Delivery Market, Global Outlook and Forecast 2023-2030

Advanced Parenteral Drug Delivery Market, Global Outlook and Forecast 2023-2030

  • Category:Life Sciences
  • Published on : 24 December 2022
  • Pages :96
  • Formats:
  • Report Code:SMR-7518012
OfferClick for best price

Best Price: $2320

Advanced Parenteral Drug Delivery Market Size, Share 2022


Market Analysis and Insights: Global Advanced Parenteral Drug Delivery Market

The global Advanced Parenteral Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Advanced Parenteral Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Advanced Parenteral Drug Delivery market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Advanced Parenteral Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Advanced Parenteral Drug Delivery market.

Global Advanced Parenteral Drug Delivery Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Prefillable Syringes

Injectors Cartridges

Hypodermic Syringes

IV Catheters

Other Parenteral Delivery Devices

Segment by Application

Government Hospitals

Private Hospitals and Clinics

Healthcare Organizations

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Abbott Laboratories

Amgen

Pfizer

Hoffmann-La Roche

AstraZeneca

Baxter

Dickinson

Boston Scientific

Bristol-Myers Squibb

GlaxoSmithKline

Novartis

Becton

AptarGroup

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Advanced Parenteral Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Advanced Parenteral Drug Delivery, with price, sales, revenue, and global market share of Advanced Parenteral Drug Delivery from 2019 to 2022.

Chapter 3, the Advanced Parenteral Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Advanced Parenteral Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Advanced Parenteral Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Advanced Parenteral Drug Delivery.

Chapter 13, 14, and 15, to describe Advanced Parenteral Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Advanced Parenteral Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Advanced Parenteral Drug Delivery Market, Global Outlook and Forecast 2023-2030
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 96 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Advanced Parenteral Drug Delivery Market Overview
1.1 Product Overview and Scope of Advanced Parenteral Drug Delivery
1.2 Advanced Parenteral Drug Delivery Segment by Type
1.2.1 Global Advanced Parenteral Drug Delivery Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Prefillable Syringes
1.2.3 Injectors Cartridges
1.2.4 Hypodermic Syringes
1.2.5 IV Catheters
1.2.6 Other Parenteral Delivery Devices
1.3 Advanced Parenteral Drug Delivery Segment by Application
1.3.1 Global Advanced Parenteral Drug Delivery Sales Comparison by Application: (2023-2030)
1.3.2 Government Hospitals
1.3.3 Private Hospitals and Clinics
1.3.4 Healthcare Organizations
1.3.5 Others
1.4 Global Advanced Parenteral Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Advanced Parenteral Drug Delivery Revenue 2018-2030
1.4.2 Global Advanced Parenteral Drug Delivery Sales 2018-2030
1.4.3 Advanced Parenteral Drug Delivery Market Size by Region: 2018 Versus 2022 Versus 2030
2 Advanced Parenteral Drug Delivery Market Competition by Manufacturers
2.1 Global Advanced Parenteral Drug Delivery Sales Market Share by Manufacturers (2018-2023)
2.2 Global Advanced Parenteral Drug Delivery Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Advanced Parenteral Drug Delivery Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Advanced Parenteral Drug Delivery Manufacturing Sites, Area Served, Product Type
2.5 Advanced Parenteral Drug Delivery Market Competitive Situation and Trends
2.5.1 Advanced Parenteral Drug Delivery Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Advanced Parenteral Drug Delivery Players Market Share by Revenue
2.5.3 Global Advanced Parenteral Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Advanced Parenteral Drug Delivery Retrospective Market Scenario by Region
3.1 Global Advanced Parenteral Drug Delivery Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Advanced Parenteral Drug Delivery Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.3.1 North America Advanced Parenteral Drug Delivery Sales by Country
3.3.2 North America Advanced Parenteral Drug Delivery Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.4.1 Europe Advanced Parenteral Drug Delivery Sales by Country
3.4.2 Europe Advanced Parenteral Drug Delivery Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Advanced Parenteral Drug Delivery Market Facts & Figures by Region
3.5.1 Asia Pacific Advanced Parenteral Drug Delivery Sales by Region
3.5.2 Asia Pacific Advanced Parenteral Drug Delivery Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.6.1 Latin America Advanced Parenteral Drug Delivery Sales by Country
3.6.2 Latin America Advanced Parenteral Drug Delivery Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Advanced Parenteral Drug Delivery Market Facts & Figures by Country
3.7.1 Middle East and Africa Advanced Parenteral Drug Delivery Sales by Country
3.7.2 Middle East and Africa Advanced Parenteral Drug Delivery Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Advanced Parenteral Drug Delivery Historic Market Analysis by Type
4.1 Global Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
4.2 Global Advanced Parenteral Drug Delivery Revenue Market Share by Type (2018-2023)
4.3 Global Advanced Parenteral Drug Delivery Price by Type (2018-2023)
5 Global Advanced Parenteral Drug Delivery Historic Market Analysis by Application
5.1 Global Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2023)
5.2 Global Advanced Parenteral Drug Delivery Revenue Market Share by Application (2018-2023)
5.3 Global Advanced Parenteral Drug Delivery Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Advanced Parenteral Drug Delivery Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Advanced Parenteral Drug Delivery Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Advanced Parenteral Drug Delivery Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Hoffmann-La Roche
6.4.1 Hoffmann-La Roche Corporation Information
6.4.2 Hoffmann-La Roche Description and Business Overview
6.4.3 Hoffmann-La Roche Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hoffmann-La Roche Advanced Parenteral Drug Delivery Product Portfolio
6.4.5 Hoffmann-La Roche Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AstraZeneca Advanced Parenteral Drug Delivery Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Baxter Advanced Parenteral Drug Delivery Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Dickinson
6.6.1 Dickinson Corporation Information
6.6.2 Dickinson Description and Business Overview
6.6.3 Dickinson Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dickinson Advanced Parenteral Drug Delivery Product Portfolio
6.7.5 Dickinson Recent Developments/Updates
6.8 Boston Scientific
6.8.1 Boston Scientific Corporation Information
6.8.2 Boston Scientific Description and Business Overview
6.8.3 Boston Scientific Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Boston Scientific Advanced Parenteral Drug Delivery Product Portfolio
6.8.5 Boston Scientific Recent Developments/Updates
6.9 Bristol-Myers Squibb
6.9.1 Bristol-Myers Squibb Corporation Information
6.9.2 Bristol-Myers Squibb Description and Business Overview
6.9.3 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Product Portfolio
6.9.5 Bristol-Myers Squibb Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GlaxoSmithKline Advanced Parenteral Drug Delivery Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Advanced Parenteral Drug Delivery Description and Business Overview
6.11.3 Novartis Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis Advanced Parenteral Drug Delivery Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Becton
6.12.1 Becton Corporation Information
6.12.2 Becton Advanced Parenteral Drug Delivery Description and Business Overview
6.12.3 Becton Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Becton Advanced Parenteral Drug Delivery Product Portfolio
6.12.5 Becton Recent Developments/Updates
6.13 AptarGroup
6.13.1 AptarGroup Corporation Information
6.13.2 AptarGroup Advanced Parenteral Drug Delivery Description and Business Overview
6.13.3 AptarGroup Advanced Parenteral Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
6.13.4 AptarGroup Advanced Parenteral Drug Delivery Product Portfolio
6.13.5 AptarGroup Recent Developments/Updates
7 Advanced Parenteral Drug Delivery Manufacturing Cost Analysis
7.1 Advanced Parenteral Drug Delivery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Advanced Parenteral Drug Delivery
7.4 Advanced Parenteral Drug Delivery Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Advanced Parenteral Drug Delivery Distributors List
8.3 Advanced Parenteral Drug Delivery Customers
9 Advanced Parenteral Drug Delivery Market Dynamics
9.1 Advanced Parenteral Drug Delivery Industry Trends
9.2 Advanced Parenteral Drug Delivery Market Drivers
9.3 Advanced Parenteral Drug Delivery Market Challenges
9.4 Advanced Parenteral Drug Delivery Market Restraints
10 Global Market Forecast
10.1 Advanced Parenteral Drug Delivery Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Advanced Parenteral Drug Delivery by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Advanced Parenteral Drug Delivery by Type (2023-2030)
10.2 Advanced Parenteral Drug Delivery Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Advanced Parenteral Drug Delivery by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Advanced Parenteral Drug Delivery by Application (2023-2030)
10.3 Advanced Parenteral Drug Delivery Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Advanced Parenteral Drug Delivery by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Advanced Parenteral Drug Delivery by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Advanced Parenteral Drug Delivery Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Advanced Parenteral Drug Delivery Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Advanced Parenteral Drug Delivery Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Advanced Parenteral Drug Delivery Market Competitive Situation by Manufacturers in 2022
Table 5. Global Advanced Parenteral Drug Delivery Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Advanced Parenteral Drug Delivery Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Advanced Parenteral Drug Delivery Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Advanced Parenteral Drug Delivery Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Advanced Parenteral Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Advanced Parenteral Drug Delivery Manufacturing Sites and Area Served
Table 11. Manufacturers Advanced Parenteral Drug Delivery Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Advanced Parenteral Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Parenteral Drug Delivery as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Advanced Parenteral Drug Delivery Sales by Region (2018-2023) & (K Units)
Table 16. Global Advanced Parenteral Drug Delivery Sales Market Share by Region (2018-2023)
Table 17. Global Advanced Parenteral Drug Delivery Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Advanced Parenteral Drug Delivery Revenue Market Share by Region (2018-2023)
Table 19. North America Advanced Parenteral Drug Delivery Sales by Country (2018-2023) & (K Units)
Table 20. North America Advanced Parenteral Drug Delivery Sales Market Share by Country (2018-2023)
Table 21. North America Advanced Parenteral Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Advanced Parenteral Drug Delivery Revenue Market Share by Country (2018-2023)
Table 23. Europe Advanced Parenteral Drug Delivery Sales by Country (2018-2023) & (K Units)
Table 24. Europe Advanced Parenteral Drug Delivery Sales Market Share by Country (2018-2023)
Table 25. Europe Advanced Parenteral Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Advanced Parenteral Drug Delivery Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Advanced Parenteral Drug Delivery Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Advanced Parenteral Drug Delivery Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Advanced Parenteral Drug Delivery Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Advanced Parenteral Drug Delivery Revenue Market Share by Region (2018-2023)
Table 31. Latin America Advanced Parenteral Drug Delivery Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Advanced Parenteral Drug Delivery Sales Market Share by Country (2018-2023)
Table 33. Latin America Advanced Parenteral Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Advanced Parenteral Drug Delivery Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Advanced Parenteral Drug Delivery Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Advanced Parenteral Drug Delivery Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Advanced Parenteral Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Advanced Parenteral Drug Delivery Revenue Market Share by Country (2018-2023)
Table 39. Global Advanced Parenteral Drug Delivery Sales by Type (2018-2023) & (K Units)
Table 40. Global Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
Table 41. Global Advanced Parenteral Drug Delivery Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Advanced Parenteral Drug Delivery Revenue Share by Type (2018-2023)
Table 43. Global Advanced Parenteral Drug Delivery Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Advanced Parenteral Drug Delivery Sales (K Units) by Application (2018-2023)
Table 45. Global Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2023)
Table 46. Global Advanced Parenteral Drug Delivery Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Advanced Parenteral Drug Delivery Revenue Share by Application (2018-2023)
Table 48. Global Advanced Parenteral Drug Delivery Price by Application (2018-2023) & (USD/Unit)
Table 49. Abbott Laboratories Corporation Information
Table 50. Abbott Laboratories Description and Business Overview
Table 51. Abbott Laboratories Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Abbott Laboratories Advanced Parenteral Drug Delivery Product
Table 53. Abbott Laboratories Recent Developments/Updates
Table 54. Amgen Corporation Information
Table 55. Amgen Description and Business Overview
Table 56. Amgen Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Amgen Advanced Parenteral Drug Delivery Product
Table 58. Amgen Recent Developments/Updates
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Pfizer Advanced Parenteral Drug Delivery Product
Table 63. Pfizer Recent Developments/Updates
Table 64. Hoffmann-La Roche Corporation Information
Table 65. Hoffmann-La Roche Description and Business Overview
Table 66. Hoffmann-La Roche Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Hoffmann-La Roche Advanced Parenteral Drug Delivery Product
Table 68. Hoffmann-La Roche Recent Developments/Updates
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. AstraZeneca Advanced Parenteral Drug Delivery Product
Table 73. AstraZeneca Recent Developments/Updates
Table 74. Baxter Corporation Information
Table 75. Baxter Description and Business Overview
Table 76. Baxter Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Baxter Advanced Parenteral Drug Delivery Product
Table 78. Baxter Recent Developments/Updates
Table 79. Dickinson Corporation Information
Table 80. Dickinson Description and Business Overview
Table 81. Dickinson Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Dickinson Advanced Parenteral Drug Delivery Product
Table 83. Dickinson Recent Developments/Updates
Table 84. Boston Scientific Corporation Information
Table 85. Boston Scientific Description and Business Overview
Table 86. Boston Scientific Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Boston Scientific Advanced Parenteral Drug Delivery Product
Table 88. Boston Scientific Recent Developments/Updates
Table 89. Bristol-Myers Squibb Corporation Information
Table 90. Bristol-Myers Squibb Description and Business Overview
Table 91. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Product
Table 93. Bristol-Myers Squibb Recent Developments/Updates
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. GlaxoSmithKline Advanced Parenteral Drug Delivery Product
Table 98. GlaxoSmithKline Recent Developments/Updates
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Business Overview
Table 101. Novartis Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Novartis Advanced Parenteral Drug Delivery Product
Table 103. Novartis Recent Developments/Updates
Table 104. Becton Corporation Information
Table 105. Becton Description and Business Overview
Table 106. Becton Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Becton Advanced Parenteral Drug Delivery Product
Table 108. Becton Recent Developments/Updates
Table 109. AptarGroup Corporation Information
Table 110. AptarGroup Description and Business Overview
Table 111. AptarGroup Advanced Parenteral Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. AptarGroup Advanced Parenteral Drug Delivery Product
Table 113. AptarGroup Recent Developments/Updates
Table 114. Production Base and Market Concentration Rate of Raw Material
Table 115. Key Suppliers of Raw Materials
Table 116. Advanced Parenteral Drug Delivery Distributors List
Table 117. Advanced Parenteral Drug Delivery Customers List
Table 118. Advanced Parenteral Drug Delivery Market Trends
Table 119. Advanced Parenteral Drug Delivery Market Drivers
Table 120. Advanced Parenteral Drug Delivery Market Challenges
Table 121. Advanced Parenteral Drug Delivery Market Restraints
Table 122. Global Advanced Parenteral Drug Delivery Sales Forecast by Type (2023-2030) & (K Units)
Table 123. Global Advanced Parenteral Drug Delivery Sales Market Share Forecast by Type (2023-2030)
Table 124. Global Advanced Parenteral Drug Delivery Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 125. Global Advanced Parenteral Drug Delivery Revenue Market Share Forecast by Type (2023-2030)
Table 126. Global Advanced Parenteral Drug Delivery Sales Forecast by Application (2023-2030) & (K Units)
Table 127. Global Advanced Parenteral Drug Delivery Sales Market Share Forecast by Application (2023-2030)
Table 128. Global Advanced Parenteral Drug Delivery Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 129. Global Advanced Parenteral Drug Delivery Revenue Market Share Forecast by Application (2023-2030)
Table 130. Global Advanced Parenteral Drug Delivery Sales Forecast by Region (2023-2030) & (K Units)
Table 131. Global Advanced Parenteral Drug Delivery Sales Market Share Forecast by Region (2023-2030)
Table 132. Global Advanced Parenteral Drug Delivery Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 133. Global Advanced Parenteral Drug Delivery Revenue Market Share Forecast by Region (2023-2030)
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Advanced Parenteral Drug Delivery
Figure 2. Global Advanced Parenteral Drug Delivery Market Share by Type in 2022 & 2030
Figure 3. Prefillable Syringes Product Picture
Figure 4. Injectors Cartridges Product Picture
Figure 5. Hypodermic Syringes Product Picture
Figure 6. IV Catheters Product Picture
Figure 7. Other Parenteral Delivery Devices Product Picture
Figure 8. Global Advanced Parenteral Drug Delivery Market Share by Application in 2022 & 2030
Figure 9. Government Hospitals
Figure 10. Private Hospitals and Clinics
Figure 11. Healthcare Organizations
Figure 12. Others
Figure 13. Global Advanced Parenteral Drug Delivery Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 14. Global Advanced Parenteral Drug Delivery Market Size (2018-2030) & (US$ Million)
Figure 15. Global Advanced Parenteral Drug Delivery Sales (2018-2030) & (K Units)
Figure 16. Advanced Parenteral Drug Delivery Sales Share by Manufacturers in 2022
Figure 17. Global Advanced Parenteral Drug Delivery Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Advanced Parenteral Drug Delivery Players: Market Share by Revenue in 2022
Figure 19. Advanced Parenteral Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Advanced Parenteral Drug Delivery Sales Market Share by Region (2018-2023)
Figure 21. Global Advanced Parenteral Drug Delivery Sales Market Share by Region in 2022
Figure 22. Global Advanced Parenteral Drug Delivery Revenue Market Share by Region (2018-2023)
Figure 23. Global Advanced Parenteral Drug Delivery Revenue Market Share by Region in 2022
Figure 24. U.S. Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. Canada Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Germany Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. France Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. U.K. Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. Italy Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Russia Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. China Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Japan Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. South Korea Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. India Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Australia Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Taiwan Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Indonesia Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Thailand Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Malaysia Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Philippines Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Vietnam Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Mexico Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Brazil Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Argentina Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Turkey Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Saudi Arabia Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 47. U.A.E Advanced Parenteral Drug Delivery Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 48. Sales Market Share of Advanced Parenteral Drug Delivery by Type (2018-2023)
Figure 49. Manufacturing Cost Structure of Advanced Parenteral Drug Delivery
Figure 50. Manufacturing Process Analysis of Advanced Parenteral Drug Delivery
Figure 51. Advanced Parenteral Drug Delivery Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount